For Mankind (MNKD +10.3%) no bad news is good news today, as the stock rips higher following an...


For Mankind (MNKD +10.3%) no bad news is good news today, as the stock rips higher following an inline Q1 report late yesterday. Operating expenses rose by 9% Y/Y, primarily due to an increase in clinical trial related expenses.

From other sites
Comments (2)
  • BrainDamage
    , contributor
    Comments (59) | Send Message
     
    Um, it's MannKind, not Mankind.
    10 May 2013, 09:42 PM Reply Like
  • Seacap
    , contributor
    Comment (1) | Send Message
     
    Give me another 10% and you can call it anything you want.
    10 May 2013, 11:47 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs